Studies on the host-mediated action of the streptococcal preparation, OK-432, in cancer chemotherapy.
D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D001761:Bleomycin / Q000008:administration & dosage; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D007942:Leukemia, Experimental / Q000188:drug therapy; D008297:Male; D051379:Mice; D008937:Mitomycins / Q000008:administration & dosage; D012157:Mononuclear Phagocyte System / Q000187:drug effects / Q000502:physiology; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000276:immunology*; D013291:Streptococcus / Q000032:analysis; D013997:Time Factors; D014184:Transplantation, Homologous
D000903:Antibiotics, Antineoplastic; D008937:Mitomycins; D001761:Bleomycin; D003520:Cyclophosphamide